Graf W D, Sumi S M, Copass M K, Ojemann L M, Longstreth W T, Shanske S, Lombes A, DiMauro S
Department of Medicine, University of Washington, Seattle.
Ann Neurol. 1993 Jun;33(6):640-5. doi: 10.1002/ana.410330613.
Two families with a point mutation in mtDNA associated with myoclonic epilepsy and ragged-red fiber disease showed pronounced clinical heterogeneity. The mothers of the two families had adult-onset myopathy with ragged-red fibers, partial deficiency of cytochrome c oxidase, and sensory neuropathy. Members of the first family had variable clinical features of progressive ataxic-myoclonic encephalomyopathy and of the other family, primarily adult-onset myopathy. There was a point mutation from A to G at nucleotide pair 8344 located in the tRNALys gene of the mtDNA of all patients tested, three in Family 1, and the mother of Family 2. This clinical heterogeneity may reflect the effects of varying proportions of mutant and wild-type mtDNA in the different organ systems in each individual.
两个患有与肌阵挛性癫痫和破碎红纤维病相关的线粒体DNA点突变的家族表现出明显的临床异质性。这两个家族的母亲患有成年期起病的伴有破碎红纤维的肌病、细胞色素c氧化酶部分缺乏以及感觉神经病变。第一个家族的成员具有进行性共济失调性肌阵挛性脑病的可变临床特征,而另一个家族的成员主要是成年期起病的肌病。在所有检测患者(家族1中的3人以及家族2的母亲)的线粒体DNA的tRNALys基因中,核苷酸对8344处存在从A到G的点突变。这种临床异质性可能反映了每个个体不同器官系统中突变型和野生型线粒体DNA不同比例的影响。